Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature-Reference-Cited by-同舟云学术

Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature

Published:2017-09 Issue: Volume:83 Page:99-102
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Deinlein Teresa^ORCID,Lax Sigurd F.,Schwarz Thomas,Giuffrida Roberta,Schmid-Zalaudek Karin,Zalaudek Iris

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference8 articles.

1. Xeroderma pigmentosum;Kraemer,2016

2. Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab;Hauschild;Eur J Cancer,2017

3. Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810;Falchook;J Immunother Cancer,2016

4. Expression of programmed cell death ligand in cutaneous squamous cell carcinoma and treatment of locally advanced disease with pembrolizumab;Stevenson;JAMA Dermatol,2017

5. Association of oncogenic mutations in patients with advanced cutaneous squamous cell carcinoma treated with cetuximab;Picard;JAMA Dermatol,2017

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers;Frontiers in Oncology;2023-10-25

2. Mutational signatures and increased retrotransposon insertions in xeroderma pigmentosum variant skin tumors;Carcinogenesis;2023-05-17

3. Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma;Annals of Surgical Oncology;2023-03-29

4. Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report;Immunotherapy;2022-12

5. Relationship between PD-L1 expression and prognostic factors in high-risk cutaneous squamous and basal cell carcinoma;Bosnian Journal of Basic Medical Sciences;2022-10-23